Journal
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume 95, Issue 4, Pages 408-426Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09553002.2018.1490041
Keywords
Cancer; anaerobic metabolism; glycolysis; LDHA; LDH5; radiotherapy; prognosis
Ask authors/readers for more resources
The anaerobic metabolism of glucose by cancer cells, even under well-oxygenated conditions, has been documented by Otto Warburg as early as 1927. Micro-environmental hypoxia and intracellular pathways activating the hypoxia-related gene response, shift cancer cell metabolism to anaerobic pathways. In the current review, we focus on a major enzyme involved in anaerobic transformation of pyruvate to lactate, namely lactate dehydrogenase 5 (LDH5). The value of LDH5 as a marker of prognosis of cancer patients, as a predictor of response to radiotherapy (RT) and chemotherapy and, finally, as a major target for cancer treatment and radio-sensitization is reported and discussed. Clinical, translational and experimental data supporting the uniqueness of the LDHA gene and its product LDH5 isoenzyme are summarized and future directions for a metabolic treatment of cancer are highlighted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available